Individual Study / JUPITER

The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin trial

The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin trial

Initiatives -
JUPITER is a completed, randomized, double-blind, placebo-controlled trial of rosuvastatin 20 mg daily in the prevention of cardiovascular disease.
Start Year
2012
End Year
2015
Funding
AstraZeneca
Visit JUPITER

Members

Download
Investigators Contacts
  • Dr. Prof. Anthony A. Bavry
    UT Southwestern Medical Center

Design

Study design
Clinical trial cohort
Follow Up
A median of 1.9 years follow up

Marker Paper

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
17,802
Number of participants with biosamples
Supplementary Information
Men who were at least 50 years old and women at least 60 years old were eligible for the trial (no history of cardiovascular disease)

Access

Availability of data and biosamples

Data
Biosamples
Other